CINCINNATI, Jan. 7 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL) a leading, global full-service clinical research organization, today announced Candace Kendle, PharmD, Chairman and CEO, will participate in the 27th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Jan. 12, 2009 at 4:30 p.m. Pacific Standard Time.
The public is invited to listen to a live webcast of Kendle's presentation at http://www.kendle.com (click on the link provided in the Investor Events and Presentations section). An archived version can be accessed approximately three hours following Kendle's presentation and will be available until Feb. 12. Slides accompanying the presentation will be available by 4 p.m. Eastern Standard Time on Jan. 12 at http://www.kendle.com under the Investor Events and Presentations section.
Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning 90 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.
Kendle was recognized by FORTUNE magazine as one of the 100 fastest-growing companies in the United States for 2008. The company also has been recognized as "Top CRO to Work With" in the CenterWatch 2007 survey of U.S. investigative sites and was named among the top three CROs to work with in its 2008 survey of European investigative sites.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com .
|SOURCE Kendle International Inc.|
Copyright©2009 PR Newswire.
All rights reserved